International Conference on Laboratory Medicine and Biomarker Discovery - (ICLMBD-27)


4th - 5th May, 2027 | Dammam, Saudi Arabia

Multi-format (In-person/Virtual)

Submit for Presentation Attendee Registration Conference Brochure
Registration Options →

Explore conference registration categories designed for every mode of participation.

Home About Organizer Call For Paper Paper Submission Author Guidelines Registration Presentation Guidelines Organizing Committee Collaboration Agenda Do's and Dont's Invitation Letter Venue Contact Us

Important Dates

Pre-registration Deadline

4th April, 2027

Paper Submission Deadline

9th April, 2027

Last Date Of Registration

19th April, 2027

Date Of Conference

4th - 5th May, 2027

Downloads

Conference Flyer
Sample Abstract
Sample Full Paper

Call for Papers

The (ICLMBD-27) is dedicated to advancing research excellence by bringing together leading scholars, scientists, and professionals from across the globe. It provides a platform for the dissemination of high-quality research and innovative methodologies.

With a strong focus on Lab Medicine, the conference promotes research that contributes to academic depth, practical insights, and interdisciplinary knowledge integration.

Authors are invited to submit papers addressing, but not limited to, the following areas:

  • Biomarker discovery in laboratory medicine
  • Translational research in biomarker development
  • Clinical applications of laboratory biomarkers
  • Technological advancements in biomarker analysis
  • Biomarkers for early disease detection
  • Ethical considerations in biomarker research
  • Standardization of biomarker testing methods
  • Biomarkers in personalized medicine approaches
  • Impact of genomics on biomarker discovery
  • Biomarker validation and clinical trials
  • Role of biomarkers in disease prognosis
  • Interdisciplinary collaboration in biomarker research
  • Emerging biomarkers in chronic diseases
  • Biomarker discovery for infectious diseases
  • Regulatory challenges in biomarker testing
  • Patient-centered biomarker research initiatives
  • Biomarkers in cancer diagnostics and treatment
  • Data analytics in biomarker discovery
  • Biomarkers and health disparities
  • Future directions in biomarker research

Peer Review Process

All submissions will be evaluated through a structured peer-review process to ensure academic rigor and contribution to the field. Accepted papers will be presented and may be considered for publication in high-quality journals and indexed conference proceedings.

Registration Details

Secure your participation by completing the registration process at the earliest. Limited presentation slots are allocated on a first-come, first-served basis.

Publication Opportunities

High-quality submissions will be prioritized for publication opportunities in recognized journals and indexed proceedings.

Submit Your Paper Today Register Early & Reserve Your Slot